Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Cash from Investing Activities: 2009-2024

Historic Cash from Investing Activities for Avadel Pharmaceuticals (AVDL) over the last 16 years, with Dec 2024 value amounting to $51.8 million.

  • Avadel Pharmaceuticals' Cash from Investing Activities rose 49.31% to $22.9 million in Q4 2022 from the same period last year, while for Dec 2022 it was $79.7 million, marking a year-over-year increase of 40.00%. This contributed to the annual value of $51.8 million for FY2024, which is 203.37% up from last year.
  • Per Avadel Pharmaceuticals' latest filing, its Cash from Investing Activities stood at $51.8 million for FY2024, which was up 203.37% from -$50.1 million recorded in FY2023.
  • Over the past 5 years, Avadel Pharmaceuticals' Cash from Investing Activities peaked at $79.7 million during FY2022, and registered a low of -$69.7 million during FY2020.
  • In the last 3 years, Avadel Pharmaceuticals' Cash from Investing Activities had a median value of $51.8 million in 2024 and averaged $27.1 million.
  • Per our database at Business Quant, Avadel Pharmaceuticals' Cash from Investing Activities plummeted by 280.05% in 2020 and then spiked by 203.37% in 2024.
  • Avadel Pharmaceuticals' Cash from Investing Activities (Yearly) stood at -$69.7 million in 2020, then soared by 181.65% to $56.9 million in 2021, then surged by 40.00% to $79.7 million in 2022, then slumped by 162.85% to -$50.1 million in 2023, then soared by 203.37% to $51.8 million in 2024.